Role of Endotoxin and Host Cytokines in Septic Shock
- 1 September 1991
- Vol. 100 (3) , 164S-168S
- https://doi.org/10.1378/chest.100.3_supplement.164s
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- ANTIBODY IMMUNOTHERAPY OF GRAM-NEGATIVE BACTERIAL SEPSIS IN AN IMMUNOSUPPRESSED ANIMAL MODELTransplantation, 1988
- Another chapter in the long history of endotoxinNature, 1987
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Cardiovascular effects of pentobarbital in pigs, and the lack of response to naloxone in pentobarbital induced circulatory failureActa Anaesthesiologica Scandinavica, 1987
- Demonstration of Cross-Reactive Antibodies to Smooth Gram-Negative Bacteria in Antiserum to Escherichia coli J5The Journal of Infectious Diseases, 1987
- Naloxone in treatment of circulatory shock resistant to conventional therapyJournal of Molecular Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Naloxone does not alter haemodynamics in cirrhosisJournal of Hepatology, 1987
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982